2 completed, 1 recruiting, 1 terminated, 1 unknown. 3 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Placebo sublingual tablet: new trials by email Literature Review of Placebo sublingual tablet trials Research Report on Placebo sublingual tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) TNX-102 SL, Placebo sublingual tablet - Major Depressive Episode (MDE), Major Depressive Disorder (MDD) | Phase 2 | Recruiting | Tonix Pharmaceuticals, Inc. | 360 | 2026-06-25 | 2026-09-25 |
| A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR) MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet - Cataract | Phase 3 | Unknown | Melt Pharmaceuticals | 528 | 2024-05-01 | 2024-08-02 |
| The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma ODACTRA 12 SQ-HDM Sublingual Tablet, Placebo sublingual tablet - Allergic Asthma Due to Dermatophagoides Pteronyssinus | Phase 4 | Completed | Bispebjerg Hospital | 39 | 2020-01-20 | 2022-05-10 |
| A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber Sublingual allergy immunological tablet, Placebo - Allergic Rhinoconjunctivitis | Phase 3 | Terminated | ALK-Abelló A/S | 80 | 2019-11-04 | 2022-06-30 |
| House Dust Mite Allergy Trial In Children Sublingual allergy immunotherapy tablet, Placebo - Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus | Phase 3 | Completed | ALK-Abelló A/S | 1460 | 2019-10-12 | 2024-06-12 |
Rhinitis, Allergic (2) · Cataract (1) · Conjunctivitis, Allergic (1) · Depression (1) · Depressive Disorder, Major (1)
ALK-Abelló A/S (2) · Bispebjerg Hospital (1) · Melt Pharmaceuticals (1) · Tonix Pharmaceuticals, Inc. (1)
United States (3) · Austria (1) · Bulgaria (1) · Canada (1) · China (1) · Denmark (1) · France (1) · Germany (1) · Lithuania (1) · Poland (1) · Russia (1) · Slovakia (1) · Spain (1) · Ukraine (1)
Antje Schuster, MD (1) · Celeste Porsbjerg, Professor (1) · Luo Zhang, Prof. (1)